Menopausal Hormone Therapy and Risk for Cardiovascular Disease in the WHI Trial

被引：0
|
作者：
Harman, S. Mitchell [1 ]
Brinton, Eliot A. [2 ]
Naftolin, Frederick [3 ]
Merriam, George R. [4 ]
Cedars, Marcelle I. [5 ]
Freeman, Ruth G. [6 ,7 ]
Santoro, Nanette [8 ]
机构：
[1] Kronos Longev Res Inst, Phoenix, AZ 85016 USA
[2] Univ Utah, Sch Med, Salt Lake City, UT 84108 USA
[3] NYU, Sch Med, New York, NY 10016 USA
[4] Univ Washington, Sch Med, Seattle, WA 98195 USA
[5] Univ Calif San Francisco, San Francisco, CA 94115 USA
[6] Albert Einstein Coll Med, Bronx, NY 10461 USA
[7] Montefiore Med Ctr, Bronx, NY 10461 USA
[8] Univ Colorado Denver, Aurora, CO 80045 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2010年 / 153卷 / 01期
关键词：
ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; HEALTH; WOMEN;
D O I：
10.7326/0003-4819-153-1-201007060-00019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [1] Menopausal hormone therapy and cardiovascular disease
    Wenger, Nanette K.
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (10): : 1058 - 1069
  • [2] LIPOPROTEIN(A), MENOPAUSAL HORMONE THERAPY, AND CARDIOVASCULAR DISEASE RISK: THE UK BIOBANK
    Honigberg, Michael
    Natarajan, Pradeep
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1478 - 1478
  • [3] Effects of menopausal hormone replacement therapy on cardiovascular risk
    Kuttenn, F
    Gerson, M
    de Lignères, B
    [J]. PRESSE MEDICALE, 2002, 31 (10): : 468 - 475
  • [4] Hormone therapy and cardiovascular disease in the early postmenopause:: the WHI data revisited
    Pines, Amos
    Sturdee, David W.
    Birkhaeuser, Martin H.
    [J]. CLIMACTERIC, 2007, 10 (03) : 195 - 196
  • [5] Menopausal Hormone Therapy and Cardiovascular Disease Risk: Utility of Biomarkers and Clinical Factors for Risk Stratification
    Bassuk, Shari S.
    Manson, JoAnn E.
    [J]. CLINICAL CHEMISTRY, 2014, 60 (01) : 68 - 77
  • [6] Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification
    Bassuk, Shari S.
    Manson, JoAnn E.
    [J]. BIOCHIMICA CLINICA, 2015, 39 (02) : 141 - 151
  • [7] From cardiovascular protection to cardiovascular risk: the metamorphosis of menopausal hormone therapy
    Stuckey, Bronwyn G. A.
    [J]. REPRODUCTION FERTILITY AND DEVELOPMENT, 2024, 36 (10)
  • [8] Fat intake and risk of cardiovascular disease: the WHI dietary modification trial
    Claire Braybrook
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (4): : 178 - 178
  • [9] Menopausal Hormone Therapy and Cardiovascular Risk: Where are We Now?
    Anagnostis, Panagiotis
    Paschou, Stavroula A.
    Katsiki, Niki
    Krikidis, Dimitrios
    Lambrinoudaki, Irene
    Goulis, Dimitrios G.
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 564 - 572
  • [10] Hormone replacement therapy and cardiovascular risk in menopausal women.
    Simon, T
    Jaillon, P
    [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2001, 94 (02): : 132 - 138
12345